International Journal of
Reproductive Biomedicine
Thu, Nov 21, 2024
[Archive]
Volume 22, Issue 9 (September 2024)
IJRM 2024, 22(9): 709-716 |
Back to browse issues page
Ethics code: IR.KHU.REC.1400.006
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Kabiri F, Foroutan T, Pashaiasl M. Magnetic graphene oxide increases the biocompatibility and nuclear factor erythroid 2-related factor 2 antioxidant of human cumulus cells: A lab-trial study. IJRM 2024; 22 (9) :709-716
URL: http://ijrm.ir/article-1-3315-en.html
URL: http://ijrm.ir/article-1-3315-en.html
1- Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran.
2- Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. ,foroutan@khu.ac.ir
3- Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 3 & Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
2- Department of Animal Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran. ,
3- Department of Reproductive Biology, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran. 3 & Women's Reproductive Health Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
Abstract: (118 Views)
Background: Although assisted reproductive technology has been improved, the success rate is only 30%. Since the interaction between oocytes and cumulus cells (CCs) is necessary for the formation of a fertile oocyte, increasing the survival rate of CCs can improve the function of oocytes in infertile women.
Objective: This study aimed to investigate the effects of magnetic graphene oxide (MGO) nanocomposite on the biocompatibility and antioxidant activity of human CCs.
Materials and Methods: In this lab-trial study, from July 2021-2023 human CCs were collected from 37 women aged 20-37 yr and cultured in a medium containing Dulbecco’s Modified Eagle’s/F12, fetal bovine serum (10%), and penicillin-streptomycin (1%). Then CCs were treated with increasing concentrations of nano-MGO for 24, 48, and 72 hr (3[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyltetrazolium bromide) assay and flow cytometry technique were used to compare the survival rate and apoptosis of CCs before and after treatment. Western blot test was used for expressing nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant in 2 groups.
Results: The results of the present study showed that treatment with MGO increased the viability of CCs at a concentration of 50 µg/ml after 48 hr (p > 0.01). At higher doses (100 µg/ml) MGO decreased the survival rate of CCs (p > 0.05). Also, treatment with MGO at a concentration of 50 µg/ml increased the expression level of antioxidant protein Nrf2 in human CCs.
Conclusion: Our results highlight the use of MGO in a new strategy that improves CCs viability and secretion of antioxidant protein Nrf2, thereby potentially increasing in vitro fertilization outcomes.
Objective: This study aimed to investigate the effects of magnetic graphene oxide (MGO) nanocomposite on the biocompatibility and antioxidant activity of human CCs.
Materials and Methods: In this lab-trial study, from July 2021-2023 human CCs were collected from 37 women aged 20-37 yr and cultured in a medium containing Dulbecco’s Modified Eagle’s/F12, fetal bovine serum (10%), and penicillin-streptomycin (1%). Then CCs were treated with increasing concentrations of nano-MGO for 24, 48, and 72 hr (3[4, 5-dimethylthiazole-2-yl]-2, 5-diphenyltetrazolium bromide) assay and flow cytometry technique were used to compare the survival rate and apoptosis of CCs before and after treatment. Western blot test was used for expressing nuclear factor erythroid 2-related factor 2 (Nrf2) antioxidant in 2 groups.
Results: The results of the present study showed that treatment with MGO increased the viability of CCs at a concentration of 50 µg/ml after 48 hr (p > 0.01). At higher doses (100 µg/ml) MGO decreased the survival rate of CCs (p > 0.05). Also, treatment with MGO at a concentration of 50 µg/ml increased the expression level of antioxidant protein Nrf2 in human CCs.
Conclusion: Our results highlight the use of MGO in a new strategy that improves CCs viability and secretion of antioxidant protein Nrf2, thereby potentially increasing in vitro fertilization outcomes.
This article has been extracted from Ph.D. Thesis. (Fahimeh Kabiri)
Type of Study: Original Article |
Subject:
Cellular and Molecular Biology of Reproduction
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
